dc.contributor.author | ELVERDİ, Tuğrul | |
dc.contributor.author | BEŞIŞIK, Sevgi | |
dc.contributor.author | OSMANBAŞOĞLU, Emre | |
dc.contributor.author | TEMURHAN, SONAY | |
dc.contributor.author | AKGÜL, Sebahat | |
dc.contributor.author | AYDIN, Filiz | |
dc.contributor.author | NALÇACI, Meliha | |
dc.date.accessioned | 2021-03-03T17:46:54Z | |
dc.date.available | 2021-03-03T17:46:54Z | |
dc.identifier.citation | ELVERDİ T., TEMURHAN S., OSMANBAŞOĞLU E., AKGÜL S., AYDIN F., NALÇACI M., BEŞIŞIK S., "Elevated Thymidine Kinase Levels (TKI)may identify patients at high risk of disease progression in newly diagnosed multiple myeloma.", 4 th International Congress on Leukemia Lymphoma Myeloma, İstanbul, Türkiye, 22 - 25 Mayıs 2013, ss.310-311 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_4b6847c4-73f7-49d2-83fd-6ce0bc2f35b3 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/54118 | |
dc.language.iso | eng | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Tıp | |
dc.subject | Sağlık Bilimleri | |
dc.title | Elevated Thymidine Kinase Levels (TKI)may identify patients at high risk of disease progression in newly diagnosed multiple myeloma. | |
dc.type | Bildiri | |
dc.contributor.department | İstanbul Üniversitesi , İstanbul Tıp Fakültesi , Tıbbi Biyoloji Anabilim Dalı | |
dc.contributor.firstauthorID | 421824 | |